RADIATION AS SALVAGE THERAPY FOR PATIENTS WITH HODGKINS-DISEASE RELAPSING AFTER MOPP (MECHLORETHAMINE, VINCRISTINE, PREDNISONE, AND PROCARBAZINE) CHEMOTHERAPY

被引：0
|
作者：
DIEHL, LF
PERRY, DJ
TEREBELO, H
BALDWIN, PE
HURWITZ, M
KIMBALL, DB
DORN, RV
机构：
[1] WALTER REED ARMY MED CTR, HEMATOL ONCOL SERV, WASHINGTON, DC 20307 USA
[2] WALTER REED ARMY MED CTR, DEPT MED, WASHINGTON, DC 20307 USA
[3] WALTER REED ARMY MED CTR, DEPT THERAPEUT RADIOL, WASHINGTON, DC 20307 USA
来源：
CANCER TREATMENT REPORTS | 1983年 / 67卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：827 / 829
页数：3
相关论文
共 50 条
  • [31] CONVENTIONAL-DOSE SALVAGE COMBINATION CHEMOTHERAPY IN PATIENTS RELAPSING WITH HODGKINS-DISEASE AFTER COMBINATION CHEMOTHERAPY - THE LOW PROBABILITY FOR CURE
    LONGO, DL
    DUFFEY, PL
    YOUNG, RC
    HUBBARD, SM
    IHDE, DC
    GLATSTEIN, E
    PHARES, JC
    JAFFE, ES
    URBA, WJ
    DEVITA, VT
    JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (02) : 210 - 218
  • [32] MOPP CHEMOTHERAPY FOR ADVANCED HODGKINS-DISEASE - PROGNOSTIC FACTORS IN 242 PATIENTS
    PORTLOCK, CS
    ROBERTSON, AC
    TURBOW, MM
    ROSENBERG, SA
    CLINICAL RESEARCH, 1976, 24 (02): : A158 - A158
  • [33] SUPRADIAPHRAGMATIC HODGKINS-DISEASE - IS THERE A ROLE FOR MOPP CHEMOTHERAPY IN PATIENTS WITH BULKY MEDIASTINAL DISEASE
    MAUCH, P
    HELLMAN, S
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1980, 6 (07): : 947 - 949
  • [34] Treatment of Hodgkin's disease in children with alternating mechlorethamine, vincristine, procarbazine, and prednisone (MOPP) and adriamycin, bleomycin, vinblastine, and dacarbazine (ABVD) courses without radiotherapy
    vandenBerg, H
    Stuve, W
    Behrendt, H
    MEDICAL AND PEDIATRIC ONCOLOGY, 1997, 29 (01): : 23 - 27
  • [35] RECOVERY OF SPERMATOGENESIS AFTER TREATMENT FOR HODGKINS-DISEASE - LIMITING DOSE OF MOPP CHEMOTHERAPY
    DACUNHA, MF
    FULLER, L
    HAGEMEISTER, F
    CONRAD, F
    VELASQUEZ, W
    MCLAUGHLIN, P
    MEISTRICH, ML
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1983, 24 (MAR): : 120 - 120
  • [36] RECOVERY OF SPERMATOGENESIS AFTER TREATMENT FOR HODGKINS-DISEASE - LIMITING DOSE OF MOPP CHEMOTHERAPY
    DACUNHA, MF
    MEISTRICH, ML
    FULLER, LM
    CUNDIFF, JH
    HAGEMEISTER, FB
    VELASQUEZ, WS
    MCLAUGHLIN, P
    RIGGS, SA
    CABANILLAS, FF
    SALVADOR, PG
    JOURNAL OF CLINICAL ONCOLOGY, 1984, 2 (06) : 571 - 577
  • [37] THERAPY OF HODGKINS-DISEASE (HD) WITH CYCLOPHOSPHAMIDE, VINBLASTINE, PROCARBAZINE, PREDNISONE (CVPP) - 5 YEAR FOLLOWUP
    GIBBS, G
    BLOOMFIELD, CD
    PETERSON, BA
    KENNEDY, BJ
    VOSIKA, G
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1979, 20 (MAR): : 101 - 101
  • [38] CVPP (CYCLOPHOSPHAMIDE, VINBLASTINE, PROCARBAZINE, PREDNISONE) FOR ADVANCED HODGKINS-DISEASE (HD) - EFFICACY OF MAINTENANCE THERAPY
    KVOLS, LK
    DIGGS, CH
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1975, 16 (MAR): : 81 - 81
  • [39] SALVAGE CHEMOTHERAPY IN HODGKINS-DISEASE IRRADIATION FAILURES - SUPERIORITY OF DOXORUBICIN-CONTAINING REGIMENS OVER MOPP
    SANTORO, A
    VIVIANI, S
    VILLARREAL, CJR
    BONFANTE, V
    DELFINO, A
    VALAGUSSA, P
    BONADONNA, G
    CANCER TREATMENT REPORTS, 1986, 70 (03): : 343 - 348
  • [40] CAV CHEMOTHERAPY (CCNU, MELPHALAN, ETOPOSIDE) AS SALVAGE TREATMENT FOR RELAPSING OR RESISTANT HODGKINS-DISEASE
    BRUSAMOLINO, E
    CASTELLI, G
    PAGNUCCO, G
    ORLANDI, E
    MALAGO, D
    LAZZARINO, M
    BERNASCONI, C
    HAEMATOLOGICA, 1990, 75 (04) : 340 - 345
12345